DSpace About DSpace Software 日本語
 

GINMU >
01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.45 No.2 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/1717

Title: Methicillin Resistant Staphylococcus aureus (MRSA)に対するBifidobacterium breveの抗菌活性と活性物質の精製
Other Titles: ANTI-MRSA ACTIVITY OF BIFIDOBACTERIUM BREVE AND ITS PURIFICATION
Authors: 井上, 敦子
Keywords: anti-MRSA activity
culture supernatan
Bifidobacterium breve
Issue Date: 30-Apr-1994
Publisher: 奈良医学会
Citation: 奈良医学雑誌 Vol.45 No.2 p.236-247
Abstract: The staphylococci, known to be members of the normal flora of the nose, are sometimes involved in chronic sinusitis. Recently, non-chemotherapeutic approaches have assumed importance in the treatment of chronic staphylococcal infections, since the rapid emergence of resistance to commonly-employed antimicrobial drugs has made it difficult to eradicate resistant staphylococci such as a methicillin resistant Staphylococcus aureus (MRSA) from the lesion. Thus, the present study was done to show the antimicrobial activity of Bifidobacterium breve to MRSA isolated from a patient with chronic sinusitis. Using MRSA resistant to acidic condition, MRSA could not survive after day 1 in the culture supernatant of B. breve, but in the control of 0.01 M phosphate-buffered saline containing tryptic soy broth of which pH was adjusted to 4.3, growth of MRSA was not affected. This anti-MRSA activity by the culture supernatants of B. breve is active only in the acidic condition under pH 4.5. But using tryptic soy soft agar containing 1% lactose, the activity was effective at pH 7.0. Purification of the active moiety from the culture supernatant of B. breve was done with ion exchange chromatography. Investigation of the main ingredient of the active moiety was done with the Anthron, Lowry, and Orcinol methods, and the absorption spectrum was calculated. The main component of the active moiety is considered to contain nucleotide and the molecular weight of the moiety will be around 8000. Our study is in progress to isolate the active moiety exhibiting anti-MRSA activity. Therefore it may be possible to apply this anti-MRSA activity of B. breve for clinical use in future.
URI: http://hdl.handle.net/10564/1717
ISSN: 04695550
13450069
Appears in Collections:Vol.45 No.2

Files in This Item:

File Description SizeFormat
236-247p:Methicillin_Resistant_Staphylococcus_aureus_(MRSA)に対するBifidobacterium_breveの抗菌活性と活性物質の精製.pdf1.56 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback